Ignite Creation Date:
2025-12-24 @ 1:53 PM
Ignite Modification Date:
2025-12-27 @ 9:28 PM
Study NCT ID:
NCT02349295
Status:
COMPLETED
Last Update Posted:
2020-07-01
First Post:
2014-10-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-31
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-26
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-10
First Submit QC Date:
None
Study First Post Date:
2015-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-06
Results First Submit QC Date:
None
Results First Post Date:
2017-12-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-19
Last Update Post Date:
2020-07-01
Last Update Post Date Type:
ACTUAL